| SKU | ISG002370 |
| Brand | سيدوفاج |
| Categories | Medication & Treatments |
| Color | Luscious Blackberry |
| Concentrations | 1 Mg |
| Shop by Concerns | High Blood Sugar |
| Gender | Unisex |
| Shop By Goals | Blood Thinning |
| Imported Or Local | Local |
| Ingredient | Metformin hydrochloride |
| UPC | 6221043012797 |
| Product Form | Tablets |
| Specialty | Clinically Tested Oral Anti-Diabetic |
| Sub Categories | Insulin And Diabetic Medicines |
| Unit Count | 20 Tablets |
| Warning | Keep Out of Reach of Children Avoid excessive alcohol intake Not for type 1 diabetes Use under medical supervision Risk of Lactic Acidosis |
Cidophage 1 Mg 20 Tablets
Description:
Cidophage 1 mg 20 tablets is an oral anti-diabetic prescription medicine containing metformin hydrochloride, a biguanide used for the management of type 2 diabetes mellitus. It helps control high blood sugar levels in adults by reducing glucose production in the liver, improving insulin sensitivity, and enhancing glucose uptake in muscles and adipose tissue. Cidophage is typically used as an adjunct to diet and exercise and may be used alone or in combination with other anti-diabetic medications as directed by a physician.
Indications:
- Management of type 2 diabetes mellitus (non-insulin-dependent diabetes mellitus) in adults, particularly in overweight patients, when diet and exercise alone are insufficient to achieve adequate glycemic control.
- Helps reduce elevated fasting and postprandial blood glucose levels.
- May be used in combination therapy with other oral anti-diabetic agents or insulin as prescribed by a healthcare professional.
Active Ingredients / Key Components:
- Metformin hydrochloride – 1 mg per tablet (strength based on product name; exact tablet strength should be confirmed on the package as standard metformin strengths are usually higher).
- Excipients: Information on inactive ingredients (such as fillers, binders, coating agents, and preservatives) is not available in the provided data. Please refer to the official package leaflet for a complete excipient list.
Dosage & Administration / How to Use:
- Use only as prescribed by your doctor. Dosage must be individualized based on blood glucose levels, clinical response, and tolerability.
- Typical adult initial dose for metformin (general reference): 250 mg twice or three times daily with meals, gradually increased at 2-week intervals if required, up to a usual maximum of 3 g daily, divided into doses. The exact regimen for Cidophage 1 mg must follow your doctor’s instructions and the actual tablet strength.
- Take tablets with or after meals to reduce gastrointestinal side effects such as nausea or stomach upset.
- Swallow the tablet whole with a glass of water; do not crush or chew unless your doctor or pharmacist specifically advises otherwise.
- Use regularly at the same times each day for best blood sugar control.
- If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
- Do not stop taking Cidophage or change the dose without consulting your healthcare provider.
Clinical Benefits:
- Helps lower elevated blood glucose levels in type 2 diabetes, improving overall glycemic control.
- Reduces hepatic gluconeogenesis (liver glucose production), thereby decreasing fasting blood sugar.
- Enhances insulin-mediated glucose disposal in muscle and adipose tissue, improving insulin sensitivity.
- Promotes peripheral glucose utilization by increasing anaerobic glycolysis and enhancing GLUT1 (glucose transporter-1) translocation to the plasma membrane.
- May help improve lipid profile in type 2 diabetic patients (e.g., reducing triglycerides and LDL cholesterol) as part of overall metabolic control.
- Supports long-term reduction of diabetes-related complications when used consistently with diet, exercise, and regular medical follow-up.
Warnings & Contraindications:
- Contraindicated in patients with known hypersensitivity to metformin hydrochloride or any component of the formulation.
- Contraindicated in severe renal impairment or significant reduction in kidney function. Metformin accumulation may lead to lactic acidosis.
- Use with caution in patients with hepatic impairment, heart failure, dehydration, severe infection, or conditions associated with hypoxia (e.g., recent myocardial infarction, respiratory failure).
- Risk of lactic acidosis: a rare but serious metabolic complication that can occur due to metformin accumulation, particularly in patients with renal dysfunction or other predisposing conditions. Symptoms include malaise, myalgia, respiratory distress, increasing somnolence, and nonspecific abdominal distress. Seek immediate medical attention if these occur.
- Temporarily discontinue metformin before and for at least 48 hours after radiologic studies involving intravascular administration of iodinated contrast materials, or as advised by your doctor.
- Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Your doctor will decide if metformin is appropriate or if insulin or another therapy is preferred.
- Inform your doctor about all medications you are taking, including other anti-diabetic drugs, diuretics, antihypertensives, and any nephrotoxic or hepatotoxic agents.
- Avoid excessive alcohol intake (acute or chronic) while taking metformin, as this increases the risk of lactic acidosis.
- Not intended to diagnose, treat, cure, or prevent any disease without medical supervision; it is a prescription medicine for confirmed diabetes management.
- Keep out of reach of children.
Side Effects:
- Common side effects: gastrointestinal disturbances such as nausea, vomiting, diarrhea, abdominal pain, loss of appetite, and metallic taste in the mouth, especially at the start of therapy. These often improve as treatment continues or with dose adjustment.
- Less common: headache, weakness, mild skin reactions (e.g., rash), or changes in vitamin b12 absorption with long-term use.
- Serious but rare: lactic acidosis, characterized by rapid breathing, severe weakness, drowsiness, muscle pain, abdominal discomfort, or feeling very unwell. This is a medical emergency; stop the medicine and seek immediate medical attention.
- If you experience signs of severe hypoglycemia (very low blood sugar) such as sweating, tremor, confusion, or palpitations while using metformin in combination with other anti-diabetic drugs or insulin, follow your doctor’s emergency instructions and seek medical help.
- Always report persistent, bothersome, or unexpected side effects to your doctor or pharmacist.
Storage Instructions:
Store in a cool, dry place away from direct sunlight and moisture. Keep the tablets in their original blister or container, tightly closed. Do not store above the temperature specified on the package (information not available here; refer to carton). Keep out of reach of children.
Specifications:
- Product type: Prescription oral anti-diabetic medicine.
- Serving size: As prescribed by the physician (typically 1 tablet per dose).
- Count: 20 tablets per pack.
- Form: Tablet for oral administration.
- Active ingredient: Metformin hydrochloride – 1 mg per tablet (as indicated by product name; verify actual strength on the package).
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
